medroxyprogesterone has been researched along with Lupus Erythematosus, Systemic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alarcón, GS; Askanase, AD; Belmont, HM; Buyon, JP; Cronin, M; Dooley, MA; Friedman, A; Grossman, J; Hahn, BH; Hearth-Holmes, M; Kalunian, KC; Kim, MY; Licciardi, F; Lockshin, M; Manzi, S; McCune, WJ; Merrill, JT; Petri, MA; Sammaritano, L; Sigler, L; Tan, M; Von Feldt, J; Wachs, J | 1 |
Ramsey-Goldman, R | 1 |
Keisler, LW; Walker, SE | 1 |
2 trial(s) available for medroxyprogesterone and Lupus Erythematosus, Systemic
Article | Year |
---|---|
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.
Topics: Adolescent; Aged; Aged, 80 and over; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Medroxyprogesterone; Middle Aged; Postmenopause; Risk Factors | 2005 |
Does hormone replacement therapy affect disease activity in patients with systemic lupus erythematosus?
Topics: Biomarkers; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Medroxyprogesterone; Menopause; Severity of Illness Index; Treatment Outcome | 2005 |
2 other study(ies) available for medroxyprogesterone and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Summaries for patients. Hormone replacement therapy does not increase severe lupus flares.
Topics: Adolescent; Aged; Aged, 80 and over; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Medroxyprogesterone; Middle Aged; Postmenopause; Risk Factors | 2005 |
Suppression of reproductive function in autoimmune NZB/W mice: effective doses of four contraceptive steroids.
Topics: Animals; Autoimmune Diseases; Contraceptives, Oral, Synthetic; Disease Models, Animal; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Lupus Erythematosus, Systemic; Luteinizing Hormone; Medroxyprogesterone; Mice; Mice, Inbred Strains; Norethindrone; Norgestrel; Reproduction | 1987 |